Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02488408
Title Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine in Patients With AML
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors BerGenBio AS
Age Groups: adult
Covered Countries USA | ITA | DEU

No variant requirements are available.